Document is current
Any future updates will be listed below
-
Authors
Sirkis, Daniel W.
Warly Solsberg, Caroline
Johnson, Taylor P.
Bonham, Luke W.
Sturm, Virginia E.
Lee, Suzee E.
Rankin, Katherine P.
Rosen, Howard J.
Boxer, Adam L.
Seeley, William W.
Miller, Bruce L.
Geier, Ethan G.
Yokoyama, Jennifer S. https://orcid.org/0000-0001-7274-2634
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01AG062588, R01AG057234, P30AG062422, P01AG019724)
National Institute of Neurological Disorders and Stroke (U54NS123985)
Tau Consortium
- License Information
-
More Information
Article History
Received: 28 October 2022
Accepted: 21 June 2023
First Online: 18 July 2023
Declarations
:
: All participants or their surrogates provided written informed consent prior to study participation; all aspects of the studies described here were approved by the UCSF institutional review board (committee number 10–03946). The research described herein conformed to the principles of the Helsinki Declaration.
: Not applicable.
: JSY serves on the scientific advisory board for the Epstein Family Alzheimer’s Research Collaboration. ALB has served as a consultant for Aeovian, AGTC, Alector, Arkuda, Arvinas, AviadoBio, Boehringer Ingelheim, Denali, GSK, Life Edit, Humana, Oligomerix, Oscotec, Roche, Transposon, TrueBinding and Wave. The remaining authors declare that they have no competing interests.
